Dublin, Oct. 04, 2024 (GLOBE NEWSWIRE) -- The "India Rapid Test Kit Market, By Region, Competition, Forecast and Opportunities 2020-2030F" report has been added to ResearchAndMarkets.com's offering.
The India Rapid Test Kit Market was valued at USD 403.21 million in 2024, and is expected to reach USD 604.78 million by 2030, rising at a CAGR of 6.84%.
The India Rapid Test Kit Market has witnessed substantial growth in recent years, driven by the increasing demand for quick and accurate diagnostic solutions, particularly in response to public health needs during and after the COVID-19 pandemic. According to the Indian Council of Medical Research (ICMR) report dated May 18, 2023, a total of 169 antigen-based rapid test kits have been validated, including 34 revalidations, with the following demonstrating satisfactory performance. 
Key factors propelling the market include the rising prevalence of infectious diseases, growing health awareness among the population, and the government's initiatives to enhance healthcare accessibility.
Regulatory support from the Indian government, along with the establishment of stringent quality control measures, has also contributed to market growth. However, challenges such as the lack of awareness in rural areas, regulatory hurdles, and the presence of counterfeit products pose significant risks to market expansion.
Nonetheless, the outlook remains positive, with ongoing research and development aimed at enhancing test accuracy and expanding the range of diseases that can be diagnosed using rapid test kits. As healthcare continues to evolve in India, the rapid test kit market is expected to play a pivotal role in facilitating early diagnosis and improving patient outcomes, ultimately contributing to the overall efficiency of the healthcare system.
Key Market Drivers:
- Increasing Demand for Quick Diagnostics
- Technological Advancements
- Growing Health Awareness
Key Market Challenges:
- Complex Regulatory Environment
- Market Competition
Key Market Trends:
- Growing Adoption in Home Testing
- Emergence of E-commerce Platforms
Regional Insights
The southern region of India, particularly states like Tamil Nadu, Karnataka, and Andhra Pradesh, is the most dominant region in the India Rapid Test Kit Market, driven by several key factors. One significant contributor is the advanced healthcare infrastructure in Southern India, which includes well-established hospitals, diagnostic centers, and research institutions. This robust foundation allows for quicker adoption and implementation of rapid test kits, as healthcare providers are well-equipped to integrate these solutions into their practices. The region has faced substantial challenges with infectious diseases such as dengue, tuberculosis, and malaria, creating a heightened demand for quick diagnostic tools and establishing the southern region as a crucial market for rapid test kits.
Government initiatives further bolster this demand, as state governments have actively promoted healthcare programs aimed at improving disease detection and management, particularly during outbreaks, which has increased the need for rapid test kits in rural and underserved areas. Growing health awareness among the population has led to greater acceptance and proactive use of rapid diagnostic tests for self-monitoring and early diagnosis.
Key market players profiled in the report:
- SD Biosensor Healthcare Pvt. Ltd.
- J. Mitra & Co. Pvt. Ltd.
- Meril Life Sciences Pvt. Ltd.
- Tulip Diagnostics (P) Ltd.
- Oscar Medicare Pvt. Ltd.
- Angstrom Biotech Pvt. Ltd.
- Ubio Biotechnology Systems Pvt. Ltd.
- Mylab Discovery Solutions Pvt. Ltd.
- Alpine Biomedicals Pvt. Ltd.
- Abbott India Limited
Report Scope
In this report, the India Rapid Test Kit Market has been segmented into the following categories:
Type:
- Rapid Antigen Test
- Rapid Antibody Test
Product Type:
- Over the counter (OTC)
- Rapid Test Kit
Technology:
- Lateral Flow Assays
- Solid Phase
- Agglutination
- ImmunoSpot Assay
Application:
- Infectious Disease
- Glucose Monitoring
- Pregnancy & Fertility
- Toxicology
- Cardiology
- Oncology
- Others
Region:
- North
- South
- West
- East
Key Attributes
| Report Attribute | Details |
| No. of Pages | 80 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $403.21 Million |
| Forecasted Market Value (USD) by 2030 | $604.78 Million |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | India |
For more information about this report visit https://www.researchandmarkets.com/r/3ccawm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
